| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -120.20M | -179.50M | -154.60M | -700.00K | 95.10M | 88.70M |
| Gross Profit | -120.20M | -179.50M | -154.60M | -302.00M | 490.40M | 234.20M |
| EBITDA | -138.30M | 0.00 | -179.90M | -343.70M | 461.40M | 190.20M |
| Net Income | -140.90M | -205.60M | -171.30M | -341.50M | 448.50M | 185.40M |
Balance Sheet | ||||||
| Total Assets | 1.07B | 1.15B | 1.41B | 1.56B | 1.88B | 1.48B |
| Cash, Cash Equivalents and Short-Term Investments | 237.30M | 285.60M | 226.90M | 241.50M | 321.90M | 270.30M |
| Total Debt | 144.30M | 150.00M | 156.40M | 101.80M | 71.80M | 101.10M |
| Total Liabilities | 182.60M | 198.70M | 221.30M | 181.70M | 141.20M | 143.40M |
| Stockholders Equity | 896.40M | 966.00M | 1.20B | 1.38B | 1.74B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | -31.40M | -25.10M | -17.90M | -23.80M | 10.30M | -200.30M |
| Operating Cash Flow | -31.40M | -25.10M | -17.90M | -23.50M | 10.50M | -27.20M |
| Investing Cash Flow | 111.10M | 82.90M | -4.40M | -2.30M | 26.30M | 49.30M |
| Financing Cash Flow | -53.60M | -42.90M | 34.70M | 8.80M | -58.30M | -16.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £501.03M | 15.15 | ― | 5.73% | ― | ― | |
72 Outperform | £100.52M | 13.05 | 30.60% | 8.61% | -11.43% | -17.65% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £119.73M | 35.90 | 1.79% | 3.29% | -9.37% | ― | |
66 Neutral | £941.21M | 15.00 | 5.19% | 2.47% | 66.53% | 100.92% | |
63 Neutral | £904.67M | 8.39 | 8.92% | ― | 11.00% | ― | |
50 Neutral | £501.79M | -3.95 | -14.23% | ― | ― | 33.10% |
IP Group has flagged a likely writedown in the value of its stake in Pulmocide after the portfolio company terminated its Opera-T Phase 3 trial of the antifungal treatment opelconazole in patients with refractory invasive pulmonary aspergillosis. Pulmocide, in which IP Group holds a 12% interest currently valued at £28.1m, will now review the unblinded trial data to assess future options for the programme, while IP Group plans a significant reduction in the asset’s carrying value as part of its year-end process but maintains that its broader pipeline of new and maturing investments and licence portfolio underpins its confidence in delivering medium-term returns for shareholders.
The most recent analyst rating on (GB:IPO) stock is a Hold with a £59.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced its month-end disclosure of voting rights and capital, revealing that the company has 883,427,642 shares in issue with no shares held in treasury. This information is crucial for shareholders as it affects their calculations regarding their interest in the company’s share capital, in compliance with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has completed a £20 million extension to its share buyback programme, purchasing a total of 157,968,634 shares at an average price of 47.5 pence per share, amounting to £75 million. This move is part of the company’s capital allocation strategy, with all acquired shares being cancelled, and it highlights the company’s commitment to optimizing shareholder value while maintaining flexibility for future buybacks based on portfolio realisations.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a transaction involving the repurchase of 366,813 ordinary shares as part of its ongoing share buyback program. This move aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure. Following this transaction, IP Group now has 883,427,642 ordinary shares in issue with voting rights, which could impact shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, a company listed on the London Stock Exchange, has announced a share buyback transaction where Numis Securities Limited, trading as Deutsche Numis, repurchased 397,632 ordinary shares on behalf of the company. This buyback is part of an ongoing programme aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares. Following this transaction, IP Group now has 883,794,455 ordinary shares in issue with voting rights, which could impact shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc announced that its portfolio company, Artios Pharma Ltd, has completed an oversubscribed $115 million Series D financing round. The funds will be used to expand clinical trials for Artios’ lead program, alnodesertib, in pancreatic and colorectal cancer, and to initiate a Phase 2 trial for ART6043 in breast cancer. This financing round, co-led by SV Health Investors and RA Capital Management, underscores Artios’ potential in the DNA damage response field, aiming to deliver first-in-class cancer treatments and strengthen its market position.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, a company listed on the London Stock Exchange, has announced a share buyback transaction where 425,000 ordinary shares were repurchased as part of its ongoing buyback program. The shares were bought at prices ranging from 59.40 to 63.00 pence and will be cancelled to reduce the number of shares in circulation, impacting the company’s share capital structure. This move is part of IP Group’s strategy to manage its capital and potentially enhance shareholder value.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a share buyback transaction where 556,000 ordinary shares were repurchased at an average price of 60.4406 pence per share. This move is part of an ongoing buyback program intended to reduce the number of shares in circulation, potentially increasing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 362,000 ordinary shares as part of its ongoing share buyback program, with the highest price paid per share being 60.50 GBp and the lowest 58.40 GBp. This move is intended to reduce the number of shares in circulation, potentially increasing shareholder value and impacting the company’s market positioning by signaling confidence in its financial health.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 366,000 ordinary shares as part of its ongoing share buyback program. The shares were bought at an average price of 60.8345 pence each and will be cancelled to reduce the number of shares in circulation, impacting shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, listed on the London Stock Exchange, has announced the repurchase of 328,979 ordinary shares as part of its ongoing share buyback program. The shares, purchased at an average price of 61.8317 pence, will be cancelled to reduce the number of shares in circulation, impacting shareholder calculations under the FCA’s rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a share buyback transaction where 382,000 ordinary shares were repurchased on the London Stock Exchange at an average price of 60.4656 pence per share. This move is part of an extended buyback program aimed at reducing the number of shares in circulation, thereby potentially increasing shareholder value. Following the transaction, the company now has 886,230,066 ordinary shares in issue, which may impact shareholder calculations under regulatory guidelines.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 375,000 ordinary shares as part of its ongoing share buyback program, with the highest price paid per share being 61.50 GBp and the lowest at 60.10 GBp. This move is aimed at reducing the number of shares in circulation, potentially increasing shareholder value and adjusting the company’s capital structure, which may have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a share buyback transaction where 370,000 ordinary shares were repurchased on the London Stock Exchange. This move is part of an extended share buyback program aimed at reducing the number of shares in circulation, potentially enhancing shareholder value and impacting the company’s market positioning.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 350,000 ordinary shares as part of its ongoing share buyback program, which aims to reduce the number of shares in circulation. This move is expected to impact the company’s share structure and provide shareholders with updated information for regulatory compliance purposes.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced that as of the end of October 2025, the company has 888,089,066 shares in issue, with no shares held in treasury. This disclosure is significant for shareholders as it affects their calculations regarding share capital interests under the Financial Conduct Authority’s rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a share buyback transaction where it repurchased 345,000 ordinary shares on the London Stock Exchange through Deutsche Numis. This move is part of an extended buyback program aimed at reducing the number of shares in circulation, potentially increasing shareholder value. The repurchased shares will be canceled, leaving the company with 888,089,066 shares in issue. This action may influence shareholder calculations under the FCA’s Disclosure Guidance and Transparency Rules, reflecting the company’s strategic financial management.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a transaction involving the repurchase of 278,000 ordinary shares as part of its ongoing share buyback program. The repurchased shares will be cancelled, reducing the total number of shares in circulation, which could potentially enhance shareholder value by increasing earnings per share. This move is part of a strategic effort to manage the company’s capital structure and improve market positioning.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a share buyback transaction, purchasing 330,247 ordinary shares on the London Stock Exchange through Deutsche Numis as part of its ongoing buyback program. This move will reduce the total number of shares in circulation, potentially enhancing shareholder value by increasing earnings per share and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, a company listed on the London Stock Exchange, has announced the repurchase of 340,000 ordinary shares as part of its ongoing share buyback program. The shares were acquired at a volume-weighted average price of 58.5024 pence per share and will be cancelled to reduce the number of shares in issue. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc announced the repurchase of 299,279 ordinary shares as part of its ongoing share buyback program, with the shares being purchased at a volume-weighted average price of 57.5878 pence. This move is intended to reduce the number of shares in circulation, potentially enhancing shareholder value and impacting the company’s market positioning by signaling confidence in its financial health.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 349,000 ordinary shares as part of its ongoing share buyback program. This move aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure. Following this transaction, the company now has 890,209,592 shares in issue, which will be used for shareholder voting rights calculations.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, listed on the London Stock Exchange, has executed a share buyback program, purchasing 351,000 ordinary shares through Deutsche Numis. This move is part of an extended buyback initiative announced earlier in June 2025. The repurchased shares will be canceled to reduce the total number of shares in circulation, impacting shareholder calculations under the FCA’s rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 310,388 ordinary shares as part of its ongoing share buyback program. This move is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and signaling confidence in the company’s financial health. The repurchase, executed by Deutsche Numis, reflects the company’s strategic focus on optimizing its capital structure and enhancing shareholder value.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the repurchase of 310,388 ordinary shares as part of its ongoing share buyback program. This transaction, conducted by Deutsche Numis, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, a company listed on the London Stock Exchange, has announced a transaction involving the repurchase of 400,000 ordinary shares as part of its ongoing share buyback program. This move is aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value. The repurchased shares will be canceled, leaving the company with 891,219,980 ordinary shares in issue. This action is part of a broader strategy to manage the company’s capital structure and may have implications for shareholder voting rights and market perception.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a transaction involving the repurchase of 413,000 ordinary shares as part of its ongoing share buyback programme. The repurchased shares will be canceled to reduce the total number of shares in circulation, which now stands at 891,619,980. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc, a company listed on the London Stock Exchange, announced the repurchase of 425,000 ordinary shares as part of its ongoing share buyback program. The shares were bought at prices ranging from 56.40 to 57.50 pence per share, with a volume-weighted average price of 56.6976 pence. This transaction reduces the total number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder calculations under FCA rules.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced an update on potential future revenue from obesity drug candidates developed by Metsera, Inc., following Metsera’s acquisition by Pfizer, Inc. for up to $7.3 billion. IP Group holds financial exposure to Metsera’s drug programmes, including MET-097i, which has shown promising Phase 2b results and is set to enter Phase 3 trials. This development positions IP Group to benefit from sustainable royalty income, contingent on the approval and commercial success of these therapies, which could ease healthcare pressures with improved drug delivery and efficacy.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced the purchase of 397,000 of its own ordinary shares as part of an ongoing share buyback program. This move, facilitated by Deutsche Numis, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc announced the repurchase of 385,000 ordinary shares as part of its ongoing share buyback program, with the highest price paid per share being 55.00 GBp. This move aims to reduce the number of shares in circulation, potentially increasing shareholder value and adjusting the company’s capital structure, which may impact shareholder voting rights and market positioning.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc has announced a recent transaction involving the repurchase of 364,000 ordinary shares as part of its ongoing share buyback program. This move, executed through Deutsche Numis, aims to reduce the number of shares in circulation, potentially enhancing shareholder value. The repurchased shares will be canceled, leaving the company with 893,549,905 shares in issue. This strategic action reflects IP Group’s commitment to managing its capital structure effectively and may influence shareholder interests and market perceptions.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
IP Group plc announced that its portfolio company, Monolith Ltd, is being acquired by CoreWeave, Inc., a Nasdaq-listed company. Monolith, which specializes in AI software for engineering teams, will enhance CoreWeave’s AI cloud platform, aiming to accelerate industrial innovation and product development. This acquisition is part of CoreWeave’s strategy to expand its AI capabilities across industries, providing tools to solve complex engineering problems. The acquisition underscores IP Group’s successful investment strategy in deeptech, marking another positive exit from its portfolio.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.